International Conference on Intellectual Property and Development
The Role of IP and Innovation in Addressing Global Public Health Challenges: Fostering Technological Transfer and Collaborations
This Conference will bring together speakers from intergovernmental organizations (IGOs), non-governmental organizations (NGOs), governments, academia and the private sector to exchange about the importance of IP and innovation in supporting global public health needs through the promotion of technological transfer and partnerships. The Conference will discuss strategies and tools to foster and build innovation capacity, encourage technology transfer and local production of medical products, as well as promote information sharing on IP rights to improve access to medicines and other health products for public health purposes. The Conference will explore IP-related solutions proposed by stakeholders, analyze various policy choices, and learn from successful partnerships from all over the world.
Hasan Kleib Deputy Director General, Regional and National Development Sector, WIPO
High Level Dialogue on the Role of IP and Innovation in Addressing Global Public Health Challenges: Fostering Technological Transfer and Collaborations (9.15 – 10.15)
The High-Level Dialogue aims to highlight the role of IP in fostering innovation, technology transfer and collaboration, while addressing global health challenges in a post-pandemic era. It looks at the way in which public policies, including national IP policies, can incentivize innovation, technology transfer and access to health technologies through the strategic use of IP in this area.
Moderator and Panelists
Moderator: Edward Kwakwa Assistant Director General, Global Challenges and Partnerships Sector, WIPO
Speaker: H. E. Carlos Gabriel Alvarenga Cardoza Vice Minister, Vice Ministry of Health Management and Development, El Salvador
Speaker: H.E. Sayedur Rahman Special Assistant, Ministry of Health and Family Welfare, Bangladesh
Speaker: Yukiko Nakatani Assistant Director-General, Access to Medicines and Health Products and Acting Assistant Director-General, Antimicrobial Resistance, World Health Organization (WHO)
Panel 1: IP as a Tool for Incentivizing Innovation and Ensuring Access to the Health Technology Sector (10.45 – 12.15)
Multiple stakeholders cooperate within health innovation ecosystems to improve quality of life, patient care and health systems. In this complex environment, innovators face challenges, such as limited financial resources and insufficient health infrastructure, that may affect their growth and innovation processes. Balanced laws and policies at different levels are key to enabling IP as an instrument to achieve innovation and access to health technologies. During this session, panelists will look at various IP tools and strategies that may encourage innovation, local production of and access to health technologies, especially in developing and least-developed countries.
Moderator and Panelists
Moderator: H. E. Pimchanok Vonkorpon Pitfield Ambassador and Permanent Representative of Thailand to the World Trade Organization (WTO) and WIPO
Speaker: Tae Hee Kim
Principal Researcher, Korea Institute of Industrial Technology, Republic of Korea
Speaker: Lonias Ndlovu Director, School of Law, University of Venda, South Africa
Speaker: Ellen ‘t Hoen Director, Medicines Law & Policy, Kingdom of the Netherlands
Speaker: Komal Kalha Deputy Director, IP and Trade,
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Switzerland
Case Study: Graziela Ferrero Zucoloto Coordinator of Science, Technology and Innovation,
Institute for Applied Economic Research, Brazil
Panel 2: IP Incentives for Antimicrobial Resistance (AMR) technologies (13.45 – 15.15)
The misuse and overuse of antibiotics in human health, food-animal production and agriculture, as well as environmental factors, such as pollution and poor waste management, have contributed to the spread of Antimicrobial Resistance (AMR) and Multidrug Resistance (MDR). Effective responses to AMR/MDR require effort by both the public and private sectors to develop and disseminate new diagnostics and treatments on a global scale, as well as to adapt them to local needs, while guaranteeing accessibility. During this session, panelists will discuss the role of IP in promoting innovative solutions and technologies to monitor and reduce the impact of antibiotics in the health, agricultural and environmental sectors to combat AMR and MDR.
Moderator and Panelists
Moderator: H.E. Francisca Elizabeth Méndez Escobar Ambassador and Permanent Representative of Mexico to the United Nations Office and other international organizations
Speaker: Jean Pierre Nyemazi Acting Director, Global Coordination and Partnership Department, WHO, and Quadripartite Joint Secretariat on AMR, WHO, Food and Agriculture Organization (FAO), UN Environment Programme (UNEP), World Organisation for Animal Health (WOAH)
Speaker: Samantha Johnson, Director, Corporate and Commercial Policy, GSK, United Kingdom
Speaker: Eduardo A. Undurraga Associate Professor, School of Government, Pontificia Universidad Católica de Chile, Chile
Case study: Karim Wanga Pharmaceutical Expert, Intergovernmental Authority on Development in Eastern Africa
Panel 3: Innovation for Health Safety at Work (15.30 – 17.00)
A sustainable workplace relies on continuing support for safety measures for the workforce. Oftentimes, workers face multiple challenges in their daily routine, ranging from the use of counterfeit equipment to the lack of adequate training to the unnecessary exposure of risks and dangers in the workplace. During this session, panelists will discuss how to respond to these challenges, and the role of partnerships and innovation to mitigate these challenges.
Moderator and Panelists
Moderator: H. E. Ms. Julia Imene-Chanduru Ambassador and Permanent Representative of the Republic of Namibia to the United Nations Office and other international organizations
Speaker: Kurt Van Ruyskensvelde Member of the Occupational Health and Safety Group,
International Union of Railways (UIC), and Infrabel, Belgium
Speaker: Fatma Lestari Director, Disaster Risk Reduction Centre, and Professor, Occupational Health & Safety Department, Faculty of Public Health, Universitas Indonesia, Indonesia
Speaker: Joana Eva Dodoo Senior Lecturer, University of Cape Coast, Ghana
Case Study: Andrés Acuña Vice President, Costa Rican Medical Devices Cluster, Costa Rica
Concluding Dialogue on opportunities for the future (17.00 – 18.00)
Selected speakers from previous panels (one from each) will highlight some key messages from their respective panels and will share additional reflections on the main debates held during the Conference. The dialogue will be organized around a list of questions that the Moderator would ask to the speakers, with a view to drawing conclusions and identifying concrete takeaways.
Moderator and Panelists
Moderator: Marion (Amy) Dietterich Director, Global Challenges Division, WIPO
Speaker: Jean Pierre Nyemazi
Acting Director, Global Coordination and Partnership Department, WHO, and Quadripartite Joint Secretariat on AMR, WHO, FAO, UNEP, WOAH
Speaker: Komal Kalha Deputy Director, IP and Trade,
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Switzerland
Speaker: Ellen ‘t Hoen
Director, Medicines Law & Policy, Kingdom of the Netherlands
Speaker: Andrés Acuña
Vice President, Costa Rican Medical Devices Cluster, Costa Rica
Speaker: Boonrat Lohwongwatana
Chief Executive Officer, Meticuly, Thailand
Closing (18.00 – 18.10)
Hasan Kleib WIPO Deputy Director General, Regional and National Development Sector
